Chapter 23- Chronic and End-Stage Renal Disease

Description

IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:

1. List the risk factors for progression of chronic kidney disease (CKD).
2. Explain the mechanisms associated with progression of CKD.
3. Identify the desired outcomes for treatment of CKD.
4. Develop a therapeutic approach to slow progression of CKD, including lifestyle modifications and pharmacologic therapies.
5. Identify specific consequences associated with CKD.
6. Design an appropriate therapeutic approach to specific consequences associated with CKD.
7. Recommend an appropriate monitoring plan to assess the effectiveness of pharmacotherapy for CKD and specific consequences.
8. Educate patients with CKD about the disease state, the specific consequences, lifestyle modifications, and pharmacologic therapies used for treatment of CKD.

Courses Offered